S&P 500 Futures
(0.19%) 5 141.50 points
Dow Jones Futures
(0.18%) 38 510 points
Nasdaq Futures
(0.26%) 17 892 points
Oil
(-0.99%) $83.02
Gas
(1.61%) $1.954
Gold
(-0.27%) $2 340.80
Silver
(0.84%) $27.48
Platinum
(0.11%) $923.10
USD/EUR
(-0.21%) $0.933
USD/NOK
(-0.23%) $11.00
USD/GBP
(-0.28%) $0.798
USD/RUB
(1.00%) $92.80

实时更新: Xvivo Perfusion AB (publ) [XVIVO.ST]

交易所: STO 部门: Healthcare 工业: Medical Devices
最后更新时间29 Apr 2024 @ 15:10

-0.13% SEK 372.50

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 15:10):

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific...

Stats
今日成交量 5 160.00
平均成交量 65 041.00
市值 11.73B
EPS SEK0.750 ( 2024-04-26 )
下一个收益日期 ( SEK0.570 ) 2024-07-12
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E 112.20
ATR14 SEK0.716 (0.19%)

音量 相关性

長: -0.01 (neutral)
短: 0.52 (weak)
Signal:(48.22) Neutral

Xvivo Perfusion AB (publ) 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Xvivo Perfusion AB (publ) 相关性 - 货币/商品

The country flag 0.07
( neutral )
The country flag 0.18
( neutral )
The country flag 0.52
( weak )
The country flag -0.22
( neutral )
The country flag 0.15
( neutral )
The country flag 0.21
( neutral )

Xvivo Perfusion AB (publ) 财务报表

Annual 2023
营收: SEK597.54M
毛利润: SEK416.91M (69.77 %)
EPS: SEK3.07
FY 2023
营收: SEK597.54M
毛利润: SEK416.91M (69.77 %)
EPS: SEK3.07
FY 2022
营收: SEK415.29M
毛利润: SEK296.96M (71.51 %)
EPS: SEK0.620
FY 2021
营收: SEK258.39M
毛利润: SEK188.28M (72.87 %)
EPS: SEK0.0777

Financial Reports:

No articles found.

Xvivo Perfusion AB (publ)

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。